Over the past decade the application of gene therapy of retinal diseases such as glaucoma has produced promising results. However, optic nerve regeneration and restoration of vision in patients ...

A linkage analysis study was performed on a single large family with juvenile-onset primary open-angle glaucoma (POAG ... of chromosome lq that harboured a gene for juvenile-onset POAG.

Gene therapy for glaucoma aims to stop and reverse vision loss associated with RGC death, by delivering neuroprotective and anti-apoptotic genes to RGCs and other support cells. However ...

Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...

The future of glaucoma research holds tremendous potential for improving diagnosis, treatment, and patient outcomes. It is AI, gene therapy and stem cell which are revolutionizing glaucoma care by ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders.

Unlike older male eye cells, which showed a consistent immune response pattern, older female eye cells appeared to experience ...

"We believe the next evolution in treating HPP will be a gene therapy in which a single injected dose will provide a lifelong treatment for patients," said Millán. In a paper published January 12 ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research ...

Glaucoma, a leading cause of irreversible blindness worldwide, is a complex eye disease characterized by progressive damage ...